Its amino-acid sequence is highly conserved across many species, such as human, mouse, rat, bovine, and rhesus monkey
This is called prior authorization
The average HbA1c reduction may have been attenuated by floor effect, as a high proportion of participants approached near-normal glycaemic levels
In that trial, participants with type 2 diabetes on the highest dose achieved: Average HbA1c reduction of 2.02 percentage points Average weight loss of 16.9% over 36 weeks A high proportion of participants reaching HbA1c below 7%, which is the standard clinical target The weight loss in the diabetes population was lower than in the non-diabetes population, which is consistent with what we see across all GLP-1 class drugs
[DOI] [PMC free article] [PubMed] [Google Scholar] 16.Peng S, Lin A, Jiang A, Zhang C, Zhang J, Cheng Q, et al